SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-13
👔
Hepion Pharmaceuticals, Inc.
@HEPA_InsiderForm 4 Filing: Appajosyula Sireesh Buys $100,000 of $HEPA
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Hepion Pharmaceuticals, Inc.
Ticker: $HEPA
Transaction Value
$100,000
Price/Share: $0.05
transaction date
2026-08-03
Shares: 2,000,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Appajosyula Sireesh, holds the title of Chief Operating Officer at Hepion Pharmaceuticals, Inc..
On 2026-08-03, the insider transacted 2,000,000 shares.The shares were transacted at a weighted average price of $0.05 per share, resulting in a total market-relevant value of $100,000.
Executive Summary Summary
Appajosyula Sireesh (Chief Operating Officer) bought $100K of $HEPA
Post-Transaction Position: 3,250,000 shares
SEC Accession No: 0001493152-26-037490 (CIK: 1901565)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.